An artificial intelligence algorithm can detect COVID-19 on chest radiographs with accuracy and speed
DeepCOVID-XR: An Artificial Intelligence Algorithm to Detect COVID-19 on Chest Radiographs Trained and Tested on a Large US Clinical Dataset – Radiology Editorial: The Potential of Artificial Intelligence to Analyze Chest Radiographs for Signs of COVID-19 Pneumonia Commentaries: AI system bests radiologists in spotting COVID-19 in lungs – CIDRAP AND AI detects COVID-19 on chest […]
The post An artificial intelligence algorithm can detect COVID-19 on chest radiographs with accuracy and speed appeared first on Links Medicus.
Long Covid: Comprehensive health assessment three months after recovery from acute COVID-19 revealed problems in several health domains in a substantial number of patients
Comprehensive health assessment three months after recovery from acute COVID-19 – Clinical Infectious Diseases
The post Long Covid: Comprehensive health assessment three months after recovery from acute COVID-19 revealed problems in several health domains in a substantial number of patients appeared first on Links Medicus.
Randomized trial: Nebulized magnesium does not benefit children with acute refractory asthma treated in the emergency department
Effect of Nebulized Magnesium vs Placebo Added to Albuterol on Hospitalization Among Children With Refractory Acute Asthma Treated in the Emergency Department: A Randomized Clinical Trial – JAMA (free for a limited period) Commentary: Nebulized Magnesium Of Little Value for Emergency Tx of Kids’ Asthma Attacks – Physician’s Weekly Commentary on Twitter This RCT […]
The post Randomized trial: Nebulized magnesium does not benefit children with acute refractory asthma treated in the emergency department appeared first on Links Medicus.
CDC Study showing decline in SARS-CoV-2 antibodies after infection suggests antibody surveys underestimate infections
Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020 – CDC Morbidity and Mortality Weekly Report Commentary: COVID-19 antibody surveys underestimate infections: study – MedicalXpress Commentary on Twitter (Thread – Click for more) 1/?Precipitous decline in #SARSCoV2 antibodies: study participants who'd […]
The post CDC Study showing decline in SARS-CoV-2 antibodies after infection suggests antibody surveys underestimate infections appeared first on Links Medicus.
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir
Latest COVID-19 guidelines come out against bamlanivimab, remdesivir – ACP Internist
The post Latest COVID-19 guidelines come out against bamlanivimab, remdesivir appeared first on Links Medicus.
With more data on its COVID-19 vaccine, Russian institute offers new evidence of success
With more data on its COVID-19 vaccine, Russian institute offers new evidence of success – Science News release: SECOND interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose – Sputnik V […]
The post With more data on its COVID-19 vaccine, Russian institute offers new evidence of success appeared first on Links Medicus.
Cluster-randomized trial: Postexposure hydroxychloroquine does not prevent Covid-19 in healthy persons exposed to a PCR-positive case patient
A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 – New England Journal of Medicine Commentary on Twitter Another RCT in @NEJM of outpatient treatment with Hydroxychloroquine in high risk folks to prevent COVID transmission No benefit But about 10X rate of adverse events in HCQ group Happy to keep studying HCQ But it […]
The post Cluster-randomized trial: Postexposure hydroxychloroquine does not prevent Covid-19 in healthy persons exposed to a PCR-positive case patient appeared first on Links Medicus.
Randomized trial: Convalescent Plasma does not improve clinical status or overall mortality in severe Covid-19 pneumonia
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia – New England Journal of Medicine Commentary: New trial of convalescent plasma for covid-19 falls flat, another setback for hyped treatment – Brief19 Commentary on Twitter A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia @NEJM A well conducted RCT shows no significant […]
The post Randomized trial: Convalescent Plasma does not improve clinical status or overall mortality in severe Covid-19 pneumonia appeared first on Links Medicus.
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains – STAT
The post Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains appeared first on Links Medicus.
Emergency COVID-vaccine approvals pose a dilemma for scientists. It could complicate efforts to study long-term outcomes, such as safety, how long protection lasts and whether the jab prevents infection or just the disease
Why emergency COVID-vaccine approvals pose a dilemma for scientists – Nature
The post Emergency COVID-vaccine approvals pose a dilemma for scientists. It could complicate efforts to study long-term outcomes, such as safety, how long protection lasts and whether the jab prevents infection or just the disease appeared first on Links Medicus.